Should next-generation HER2-directed combinations move into first-line treatment for HER2-positive gastroesophageal cancer?
@KlempnerSam, MD and @YJanjigianMD, debate established therapy vs emerging combinations at #OLNGreatDebates.
https://t.co/3RwOiDYiyF
💥 LEIOMYOSARCOMA simplified!
WHO 2022 👉 Spindle, Epithelioid & Myxoid types with key histologic clues 🔬
🎉 Don’t miss the Pathology Day 2025 offer — 20% OFF on WHO-based modules! 🧠
#PathologyMCQ#WHO2022#Leiomyosarcoma#PathologyDay
Digital Pathologu+Artificial Intelligence=Precision Medicin,which includes genetics, morphology, biomarkers, lifestyle, and environmental factors!🧬🔬
#DigitalPathology#AI#PrecisionMedicin
June's image of the month highlights the beauty in cellular analysis 🔬
This artwork come from Selamete Çeku, who says “My #pathart reflects the essence of the pathologist’s profession – a commitment to transforming the future of healthcare.”
Read more! https://t.co/SNZ8Ubv2er
Pathology Captures 2025 is here! 🎨🎉 thanks to all of our #pathart contributors - as always, you've smashed it out of the park 👏 visit the gallery here! https://t.co/mXnvFM4rFV
#PathX#PathTwitter
This is an example of a dermatofibrosarcoma protuberans (DFSP) arising in association with a giant cell fibroblastoma, the latter considered a forme fruste DFSP. #UMiamiPath@ModernPathology@science_press